Properties of measurements obtained during cardiopulmonary exercise testing in individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
- PMID: 32568145
- DOI: 10.3233/WOR-203170
Properties of measurements obtained during cardiopulmonary exercise testing in individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Abstract
Background: Diminished cardiopulmonary exercise test (CPET) performance indicates the physiological basis for reduced capacity for activities of daily living and work. Thus, it may be a biomarker for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Objective: To determine statistical properties of cardiac, pulmonary, and metabolic measurements obtained during CPET in people with ME/CFS.
Methods: Fifty-one females with ME/CFS and 10 sedentary females with similar age and body mass received cardiac, pulmonary, and metabolic measurements during 2 CPETs separated by 24 hours. Two-way analysis of variance and effect size calculations (Cohen's d) were used to assess the magnitude and statistical significance of differences in measurements between groups. Reliability of CPET measurements was estimated using intraclass correlation coefficients (ICC2,1). Responsiveness of CPET measurements was assessed using minimum detectable change outside the 95% confidence interval (MDC95) and coefficients of variation (CoV).
Results: CPET measurements demonstrated moderate to high reliability for individuals with ME/CFS. Comparing subjects with ME/CFS and control subjects yielded moderate to large effect sizes on all CPET measurements. MDC95 for all individuals with ME/CFS generally exceeded control subjects and CoVs for CPET measurements were comparable between groups.
Conclusions: CPET measurements demonstrate adequate responsiveness and reproducibility for research and clinical applications.
Keywords: Chronic Fatigue Syndrome; Myalgic Encephalomyelitis; Tests and measures; exercise testing; reliability.
Similar articles
-
Cardiopulmonary and metabolic responses during a 2-day CPET in myalgic encephalomyelitis/chronic fatigue syndrome: translating reduced oxygen consumption to impairment status to treatment considerations.J Transl Med. 2024 Jul 5;22(1):627. doi: 10.1186/s12967-024-05410-5. J Transl Med. 2024. PMID: 38965566 Free PMC article.
-
Inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO₂peak indicates functional impairment.J Transl Med. 2014 Apr 23;12:104. doi: 10.1186/1479-5876-12-104. J Transl Med. 2014. PMID: 24755065 Free PMC article.
-
Comparing Idiopathic Chronic Fatigue and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in Males: Response to Two-Day Cardiopulmonary Exercise Testing Protocol.Healthcare (Basel). 2021 Jun 5;9(6):683. doi: 10.3390/healthcare9060683. Healthcare (Basel). 2021. PMID: 34198946 Free PMC article.
-
The Prospects of the Two-Day Cardiopulmonary Exercise Test (CPET) in ME/CFS Patients: A Meta-Analysis.J Clin Med. 2020 Dec 14;9(12):4040. doi: 10.3390/jcm9124040. J Clin Med. 2020. PMID: 33327624 Free PMC article. Review.
-
Chronotropic Intolerance: An Overlooked Determinant of Symptoms and Activity Limitation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?Front Pediatr. 2019 Mar 22;7:82. doi: 10.3389/fped.2019.00082. eCollection 2019. Front Pediatr. 2019. PMID: 30968005 Free PMC article. Review.
Cited by
-
Cardiopulmonary and metabolic responses during a 2-day CPET in myalgic encephalomyelitis/chronic fatigue syndrome: translating reduced oxygen consumption to impairment status to treatment considerations.J Transl Med. 2024 Jul 5;22(1):627. doi: 10.1186/s12967-024-05410-5. J Transl Med. 2024. PMID: 38965566 Free PMC article.
-
Reduced athletic performance post-COVID-19 is associated with reduced anaerobic threshold.BMJ Case Rep. 2023 Feb 17;16(2):e250191. doi: 10.1136/bcr-2022-250191. BMJ Case Rep. 2023. PMID: 36805865 Free PMC article.
-
Recovery from Exercise in Persons with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).Medicina (Kaunas). 2023 Mar 15;59(3):571. doi: 10.3390/medicina59030571. Medicina (Kaunas). 2023. PMID: 36984572 Free PMC article.
-
Single-cell transcriptomics of the immune system in ME/CFS at baseline and following symptom provocation.Cell Rep Med. 2024 Jan 16;5(1):101373. doi: 10.1016/j.xcrm.2023.101373. Cell Rep Med. 2024. PMID: 38232699 Free PMC article.
-
Post-exertional malaise in Long COVID: subjective reporting versus objective assessment.Front Neurol. 2025 Apr 23;16:1534352. doi: 10.3389/fneur.2025.1534352. eCollection 2025. Front Neurol. 2025. PMID: 40337174 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical